OpenAI's CEO of Applications, Fidji Simo, is taking medical leave for "several weeks," according to a Bloomberg report on April 3. She's not the only executive stepping back - the company is simultaneously reshuffling its C-suite ahead of a potential IPO.
Simo joined OpenAI in August 2025 after a high-profile run as Instacart's CEO, where she led the company through an IPO that broke the longest tech listing drought in two decades. At OpenAI, she oversees product, business, technology, and engineering for the company's applications, reporting directly to Sam Altman. Simo has been open about her health history - she co-founded the Metrodora Institute in 2021 after a three-year search for a diagnosis of postural orthostatic tachycardia syndrome (POTS), a neuroimmune condition.
Alongside Simo's leave, longtime COO Brad Lightcap is moving to lead special projects, also reporting to Altman. One of his main tasks will be overseeing OpenAI's push to sell software to businesses through a joint venture with private equity firms. Denise Dresser, OpenAI's recently appointed chief revenue officer, will absorb some of Lightcap's former responsibilities.
The timing matters. OpenAI has been signaling a Wall Street debut, and losing your applications CEO and reshuffling your COO in the same announcement is not the kind of stability story investors want to hear. Lightcap's shift from COO to special projects also reads like a significant reduction in scope, even if the official framing is about strategic focus.
For ChatGPT users and developers building on OpenAI's APIs, the practical impact is probably minimal in the short term. Product roadmaps at companies this size don't pivot because one executive takes a few weeks off. But the broader pattern of leadership churn at OpenAI - from the board crisis in 2023 to the steady parade of departures since - keeps raising the same question: how much organizational upheaval can a company absorb while trying to build the most ambitious technology in a generation?